ORTHOFIX MEDICAL INC.
Ownership & governance
Executives 5Directors 10Avg age 58Avg tenure 3.8y
MC
Massimo Calafiore
Chief Executive Officer
Age 54Since 2024-01-07Profile →
+14
Executives5
Board of directors10
MP
Michael Paolucci→
Director/Board Member
Age 66Since 2016-03-15
JH
Jason Hannon→
Director/Board Member
Age 54Since 2020-06-07
JH
John Henneman→
Director/Board Member
Age 64Since 2023-01-04
SM
Shweta Singh Maniar→
Director/Board Member
Age 42Since 2023-01-04
WB
Wayne Burris→
Director/Board Member
Age 71Since 2021-09-26
AB
Alan Bazaar→
Director/Board Member
Age 56Since 2023-12-11
MF
Michael Finegan→
Chairman
Age 62Since 2024-06-17
CK
Charles Kummeth→
Director/Board Member
Age 65Since 2023-12-13
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| Engine Capital Management LP | 11.32 % | 4,575,675 |
| Juniper Investment Co. LLC | 10.99 % | 4,442,543 |
| Engine Capital Management LP | 10.86 % | 4,390,779 |
| Juniper Investment Co. LLC | 9.839 % | 3,976,959 |
| Rubric Capital Management LP | 9.207 % | 3,721,715 |
Catalog · 2026-07-09
Registry officers15
| Name | Role | Since | Shares |
|---|---|---|---|
| Julie Andrews | Director of Finance/CFO | 2024-01-14 | - |
| Massimo Calafiore | Chief Executive Officer | 2024-01-07 | - |
| Michael Finegan | Chairman | 2024-06-17 | - |
| Alan Bazaar | Director/Board Member | 2023-12-11 | - |
| Charles Kummeth | Director/Board Member | 2023-12-13 | - |
| Jason Hannon | Director/Board Member | 2020-06-07 | - |
| John Henneman | Director/Board Member | 2023-01-04 | - |
| Massimo Calafiore | Director/Board Member | 2024-01-07 | - |
Registry · as of 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus noneMean target 13Range 12–14Analysts 4
12Mean 1314
- Strong buy 1
- Buy 2
- Hold 2
Broker actions40 of 44
| Firm | Action | To | Target | Date |
|---|---|---|---|---|
| Canaccord Genuity | Maintained | Buy | 13 | 2026-08-10 |
| Barrington Research | Maintained | Outperform | 17 | 2026-07-06 |
| Canaccord Genuity | Maintained | Buy | 18 | 2026-05-22 |
| Barrington Research | Maintained | Outperform | 15 | 2026-05-22 |
| Stifel | Maintained | Buy | 15 | 2026-05-22 |
| Barrington Research | Maintained | Outperform | 17 | 2026-04-10 |
| Stifel | Maintained | Buy | 18 | 2026-03-09 |
| Canaccord Genuity | Maintained | Buy | 20 | 2026-02-26 |
| Barrington Research | Maintained | Outperform | 17 | 2026-02-25 |
| Barrington Research | Maintained | Outperform | 18 | 2026-02-17 |
| TD Cowen | Initiated | Hold | 14 | 2026-01-27 |
| Barrington Research | Maintained | Outperform | 18 | 2025-11-05 |
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.